U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Emergency Preparedness | Drugs
  4. Coronavirus (COVID-19) | Drugs
  1. Emergency Preparedness | Drugs

Coronavirus (COVID-19) | Drugs

The Center for Drug Evaluation and Research (CDER) is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic.

Please visit the webpages for contact information and to learn more about each area of activity.


Sub-Topic Paragraphs

More CDER Activities

Clinical Trial Conduct

Coordinating and managing responses to stakeholder inquiries on Clinical Trial Conduct during the COVID-19 pandemic

Drug Imports

Regulatory flexibility for imports related to the COVID-19 pandemic

Drug Registration and Listing

Ensuring companies manufacturing drugs to address the COVID-19 public health emergency can quickly register and list products with FDA

Drug Shortages

Monitoring drug supply chain for impact of COVID-19 pandemic, and working with industry to prevent and alleviate shortages

Fraudulent Activity

Protecting Americans from fraudulent/unproven products for the treatment or prevention of COVID-19

Hand Sanitizers

Help meet the increased demand for hand sanitizers during the COVID-19 public health emergency

Include/exclude header

Additional Resources

COVID-19 Treatment Hub

Provides physicians, patients, and caregivers with information about the latest research in the fight against COVID-19

Paragraph Header
CONTACT US

Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

CDER Division of Drug Information

For Updates on Twitter follow

Contact Point Twitter

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.


Back to Top